NSC 702827 is primarily investigated for its potential in cancer research, particularly as an inhibitor of specific cellular pathways involved in tumor growth. It has shown promise in preclinical studies for targeting certain types of cancer cells, making it a candidate for further development in oncology therapeutics. Researchers are exploring its efficacy in combination with other drugs to enhance its anti-cancer properties. Additionally, its role in modulating cellular signaling pathways makes it a valuable tool for studying molecular mechanisms in cancer biology. Ongoing studies aim to determine its safety and effectiveness in clinical settings.